IBDEI09Q ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4129,1,3,0)
 ;;=3^EYE VISION EXAMINATION
 ;;^UTILITY(U,$J,358.3,4129,1,4,0)
 ;;=4^V72.0
 ;;^UTILITY(U,$J,358.3,4129,2)
 ;;=^43432
 ;;^UTILITY(U,$J,358.3,4130,0)
 ;;=V72.11^^17^196^3
 ;;^UTILITY(U,$J,358.3,4130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4130,1,3,0)
 ;;=3^HEARING EXAM-FAIL SCREEN
 ;;^UTILITY(U,$J,358.3,4130,1,4,0)
 ;;=4^V72.11
 ;;^UTILITY(U,$J,358.3,4130,2)
 ;;=^334218
 ;;^UTILITY(U,$J,358.3,4131,0)
 ;;=V72.19^^17^196^1
 ;;^UTILITY(U,$J,358.3,4131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4131,1,3,0)
 ;;=3^EARS & HEARING EXAM NEC
 ;;^UTILITY(U,$J,358.3,4131,1,4,0)
 ;;=4^V72.19
 ;;^UTILITY(U,$J,358.3,4131,2)
 ;;=^334219
 ;;^UTILITY(U,$J,358.3,4132,0)
 ;;=V72.7^^17^196^81
 ;;^UTILITY(U,$J,358.3,4132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4132,1,3,0)
 ;;=3^SKIN/SENSITIZATION TESTS
 ;;^UTILITY(U,$J,358.3,4132,1,4,0)
 ;;=4^V72.7
 ;;^UTILITY(U,$J,358.3,4132,2)
 ;;=^295616
 ;;^UTILITY(U,$J,358.3,4133,0)
 ;;=V73.5^^17^196^5
 ;;^UTILITY(U,$J,358.3,4133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4133,1,3,0)
 ;;=3^SCREEN-ARBOVIRUS DIS
 ;;^UTILITY(U,$J,358.3,4133,1,4,0)
 ;;=4^V73.5
 ;;^UTILITY(U,$J,358.3,4133,2)
 ;;=^295629
 ;;^UTILITY(U,$J,358.3,4134,0)
 ;;=V73.81^^17^196^31
 ;;^UTILITY(U,$J,358.3,4134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4134,1,3,0)
 ;;=3^SCREEN-HPV
 ;;^UTILITY(U,$J,358.3,4134,1,4,0)
 ;;=4^V73.81
 ;;^UTILITY(U,$J,358.3,4134,2)
 ;;=^335323
 ;;^UTILITY(U,$J,358.3,4135,0)
 ;;=V73.88^^17^196^10
 ;;^UTILITY(U,$J,358.3,4135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4135,1,3,0)
 ;;=3^SCREEN-CHLAMYDIA
 ;;^UTILITY(U,$J,358.3,4135,1,4,0)
 ;;=4^V73.88
 ;;^UTILITY(U,$J,358.3,4135,2)
 ;;=^295832
 ;;^UTILITY(U,$J,358.3,4136,0)
 ;;=V73.89^^17^196^63
 ;;^UTILITY(U,$J,358.3,4136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4136,1,3,0)
 ;;=3^SCREEN-VIRAL DISEASE 
 ;;^UTILITY(U,$J,358.3,4136,1,4,0)
 ;;=4^V73.89
 ;;^UTILITY(U,$J,358.3,4136,2)
 ;;=^295833
 ;;^UTILITY(U,$J,358.3,4137,0)
 ;;=V74.0^^17^196^11
 ;;^UTILITY(U,$J,358.3,4137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4137,1,3,0)
 ;;=3^SCREEN-CHOLERA
 ;;^UTILITY(U,$J,358.3,4137,1,4,0)
 ;;=4^V74.0
 ;;^UTILITY(U,$J,358.3,4137,2)
 ;;=^295633
 ;;^UTILITY(U,$J,358.3,4138,0)
 ;;=V74.1^^17^196^51
 ;;^UTILITY(U,$J,358.3,4138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4138,1,3,0)
 ;;=3^SCREEN-PULMONARY TB
 ;;^UTILITY(U,$J,358.3,4138,1,4,0)
 ;;=4^V74.1
 ;;^UTILITY(U,$J,358.3,4138,2)
 ;;=^108715
 ;;^UTILITY(U,$J,358.3,4139,0)
 ;;=V74.2^^17^196^37
 ;;^UTILITY(U,$J,358.3,4139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4139,1,3,0)
 ;;=3^SCREEN-LEPROSY
 ;;^UTILITY(U,$J,358.3,4139,1,4,0)
 ;;=4^V74.2
 ;;^UTILITY(U,$J,358.3,4139,2)
 ;;=^295634
 ;;^UTILITY(U,$J,358.3,4140,0)
 ;;=V74.3^^17^196^19
 ;;^UTILITY(U,$J,358.3,4140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4140,1,3,0)
 ;;=3^SCREEN-DIPHTHERIA
 ;;^UTILITY(U,$J,358.3,4140,1,4,0)
 ;;=4^V74.3
 ;;^UTILITY(U,$J,358.3,4140,2)
 ;;=^295635
 ;;^UTILITY(U,$J,358.3,4141,0)
 ;;=V74.4^^17^196^6
 ;;^UTILITY(U,$J,358.3,4141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4141,1,3,0)
 ;;=3^SCREEN-BACT CONJUNCTIVIT
 ;;^UTILITY(U,$J,358.3,4141,1,4,0)
 ;;=4^V74.4
 ;;^UTILITY(U,$J,358.3,4141,2)
 ;;=^295636
 ;;^UTILITY(U,$J,358.3,4142,0)
 ;;=V74.5^^17^196^62
 ;;^UTILITY(U,$J,358.3,4142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4142,1,3,0)
 ;;=3^SCREEN-VENERAL DIS
 ;;^UTILITY(U,$J,358.3,4142,1,4,0)
 ;;=4^V74.5
 ;;^UTILITY(U,$J,358.3,4142,2)
 ;;=^295637
 ;;^UTILITY(U,$J,358.3,4143,0)
 ;;=V74.6^^17^196^64
 ;;^UTILITY(U,$J,358.3,4143,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI09Q
